# Altos Labs

launched around 2022 with roughly $3 billion in funding, pursuing partial cellular reprogramming for cellular rejuvenation rather than senescent-cell clearance.


Source: https://en.bioecon.ru/companies/altos-labs/
Updated: 2026-07-03

- Country: United States

## Technologies

- [Geroscience & senolytics](https://en.bioecon.ru/technology/geroscience-senolytics/)
- [Partial epigenetic reprogramming](https://en.bioecon.ru/technology/partial-epigenetic-reprogramming/)